Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2009 - 2016)

Abbott Laboratories has disclosed Liabilities from Discontinued Operations across 5 years of filings, most recently posting 245000000.0 for Q4 2016.

• Liabilities from Discontinued Operations for Q4 2016 came in at 245000000.0, down 34.32% year-over-year; the trailing twelve-month figure through Dec 2016 was 245000000.0 (down 34.32% YoY), and the FY2016 annual result was 245000000.0, down 34.32% from the prior year.
• Liabilities from Discontinued Operations came in at 245000000.0 for Q4 2016 at Abbott Laboratories, up from 60000000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 721000000.0 in Q3 2014 to a low of 1000000.0 in Q2 2014.
• The 4-year median for Liabilities from Discontinued Operations is 296500000.0 (2015), against an average of 252932187.5.
• Across the five-year window, Liabilities from Discontinued Operations plunged 99.67% in 2014 and jumped 29100.0% in 2015, its largest moves.
• Abbott Laboratories' Liabilities from Discontinued Operations stood at 386000000.0 in 2013, then tumbled by 72.02% to 108000000.0 in 2014, then surged by 245.37% to 373000000.0 in 2015, then sank by 34.32% to 245000000.0 in 2016.
• The last three Liabilities from Discontinued Operations figures came in at 245000000.0 (Q4 2016), 60000000.0 (Q3 2016), and 361000000.0 (Q2 2016), per Business Quant data.